Metoclopramide Shortage Update: What Patients Need to Know in 2026

Patients who rely on metoclopramide for gastroparesis or chronic nausea are understandably concerned whenever their pharmacy says it's out of stock. This article provides the most current information on metoclopramide availability in 2026, what's driving any stock gaps, and how to protect your access to this medication.

Is Metoclopramide on an Official Drug Shortage List in 2026?

As of 2026, oral metoclopramide (tablets and orally disintegrating tablets) is not listed as an active FDA drug shortage. The FDA maintains a public Drug Shortages Database, and oral metoclopramide formulations are not currently on it. This is good news for most patients.

However, injectable metoclopramide formulations have historically appeared on shortage lists periodically, and hospital-use formulations may experience supply disruptions more frequently than retail pharmacy stock. If you are receiving metoclopramide injections as part of chemotherapy treatment, check with your oncology team about current supply status.

Why Oral Metoclopramide Can Still Be Hard to Find Locally

"Not on the shortage list" doesn't mean "in stock everywhere." Several factors can cause local pharmacy shortages even when the drug is broadly available:

• Demand spillover from the prochlorperazine shortage: Prochlorperazine (Compazine) has been on an ongoing national shortage since 2022. Patients switching from prochlorperazine to metoclopramide have increased demand at local pharmacies.
• Multiple competing formulations: Tablets, ODT, liquid, and injectable are all stocked separately. A pharmacy may have tablets but not ODT.
• Generic market economics: With generic competition since 1985, profit margins are thin. Some manufacturers have exited the market, reducing supply resilience overall.
• API and manufacturing disruptions: Metoclopramide, like most drugs, relies on active pharmaceutical ingredient (API) suppliers, many of which are overseas. Any manufacturing issue can temporarily reduce supply.

History of Metoclopramide Supply Issues

Metoclopramide has been on the US market since 1979 (injectable) and 1980 (oral). Generic versions became available in 1985, dramatically improving supply resilience. The drug has not faced a sustained nationwide oral shortage in recent years, unlike some other antiemetics. However:

• Injectable metoclopramide has appeared on ASHP shortage notices periodically
• Broader antiemetic shortages in 2022–2024 increased pressure on all available antiemetics including metoclopramide
• The overall US drug shortage environment hit record highs in 2024, with over 300 drugs affected — which created ripple effects for many medications not on the official shortage list

What Formulations Are Most at Risk?

Based on historical patterns, the formulations most at risk for supply gaps are:

1. Injectable metoclopramide (5 mg/mL): Most vulnerable to shortages; used primarily in hospitals and cancer centers
2. Orally disintegrating tablets (ODT): Less commonly stocked than standard tablets; some pharmacies don't carry them routinely
3. Oral liquid solution: Stocked less frequently than tablets; may need to be special-ordered

What Should Patients Do Right Now?

Here's a practical action plan to protect your supply:

1. Refill before you run out. Request your refill 7–10 days before you need it, not the day you take your last dose.
2. Have a backup pharmacy. Know at least two or three pharmacies near you that carry metoclopramide.
3. Use medfinder if your pharmacy is out. medfinder calls pharmacies in your area and texts you which ones can fill your prescription — fast and without the hold-time marathon.
4. Talk to your prescriber about contingency plans. Ask in advance which alternative medications would be appropriate if you're ever unable to fill metoclopramide. This gives you a fallback plan already in place.
5. Ask about 90-day supplies. While metoclopramide is typically not prescribed for longer than 12 weeks at a stretch due to TD risk, some patients are on shorter cycles. Ask your prescriber and pharmacy if a 90-day supply (for the total duration of your treatment course) is appropriate.

Summary: Metoclopramide Availability in 2026

• Oral tablets: Not on active FDA shortage; generally available at major pharmacies
• Injectable: Historically more vulnerable to supply gaps; check with your care team
• ODT and liquid: Less commonly stocked; may require special order or pharmacy transfer

If you need help locating metoclopramide today, try medfinder. For alternative medications, see our guide on metoclopramide alternatives.